Skip to content

Search

Facing the future: Giving kids in Tuvalu a better start as their country sinks into the sea

Children in the tiny Pacific nation of Tuvalu face a unique threat that should be a wake-up call to other countries across the world.

Closing the Gap - Hitting ‘reset’ on how we measure early development in Aboriginal kids

In 2020, the National Closing the Gap partnership made improving early development of Aboriginal and Torres Strait Islander children one of its top priorities. Australia will measure progress in this area using the AEDC.

How the pandemic has shaped the mental health of our kids

Researchers went into 79 WA primary and secondary schools in 2020 and found increased levels of emotional distress among students and families.

What’s in a name?

For thousands of WA children living with undiagnosed diseases, it’s hope.

Wal-yan Respiratory Research Centre secures Telethon funding for three new research projects

Researchers from the Wal-yan Respiratory Research Centre – a powerhouse partnership between The Kids Research Institute Australia, Perth Children’s Hospital Foundation and Perth Children’s Hospital – have received funding from the Channel 7 Telethon Trust for three new research projects.

Our supporters

Learn more about the supporters of the Wal-yan Respiratory Centre

Protecting little lungs for a lifetime

Dr Denby Evans, a Wal-yan Respiratory researcher, has been awarded a $25,000 Illuminate Award for her work to change that. Funding by Helping Little Hands, the award was presented at The Kids Research Institute Australia’s 2026 Illuminate PitchFest.

SENS Motion Device: Parent Help Guide

During our 8-Year Kids Checks, ORIGINS is introducing the opportunity for parents and children to be fitted with the SENS motion device which that will measure you and your child's sleep and physical activity for seven days.

Psychiatry and Pharmacology

Dissociation can exist along a continuum from normal developmental experiences to severe and contributing to persistent mental illness and impeding normal development. It can also occur as a discreet symptom in a range of disorders or as a disorder itself, and can change depending on a number of factors such as the age and stage of development.

KMT2A-rearranged acute lymphoblastic leukaemia

KMT2A-rearranged acute lymphoblastic leukaemia (ALL) represents a high risk subtype of childhood ALL. Historical treatment strategies have comprised of intensification with conventional chemotherapy. However, outcomes have remained consistently poor compared to the advances that have been seen for other ALL subtypes, particularly for infants diagnosed before their first birthday